Gilead's IPR Bid Over 2 Gov't HIV-Prevention Patents Fails
The Patent Trial and Appeal Board on Wednesday rejected Gilead's challenges to two U.S. Department of Health and Human Services patents covering a method of preventing HIV, mainly faulting the drugmaker...To view the full article, register now.
Already a subscriber? Click here to view full article